MiYOSMART
The MiYOSMART spectacle lens can be considered as a first-line treatment for simultaneous myopic correction and myopia control, with a two-year randomized controlled trial showing robust efficacy and acceptance in children. Data for up to six years of wear in children has been published, as well as eight-year data. It can be considered as one of the best available myopia control spectacle lens designs, being superior to progressive addition and bifocal lenses.
Visit the MiYOSMART website.
HOYA
MiYOSMART
Spectacle lens for myopia correction and control with Defocus Incorporated Multiple Segments (DIMS) Technology
Central clear zone of 9.4mm with no defocus segments, for correcting distance refractive error and providing clear vision. Surrounding treatment zone of DIMS structure allows normal visual perception and myopia management simultaneously. The lens has myopic defocus segments distributed in a high-density honeycomb structure over a 33mm area. Each segment provides defocus of +3.5D. The ratio of defocus and focus areas within a pupil size is around 50:50 everywhere on the lens.
Plano to -13.00, cylindrical correction up to 4.00, prism up to 3 PD per lens
Polycarbonate 1.59. Also available in Polarised and Photochromic sun options.
Diameter (60⌀, 65⌀, 70⌀, 75⌀)
With full refraction, taking monocular pupillary distances and monocular heights.
Information
Product disclaimer
MiYOSMART has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S.
MiYOSMART.
HOYA resources
Summary of all MiYOSMART studies
Learn more about the MiYOSMART lens as an innovative and evidence-based option for myopia management, with links to the 2-year and 3-year published studies, as well as 6-year data and 8-year data. Further studies on adaptation, visual function, optics and even combination with atropine via this link.